967 related articles for article (PubMed ID: 26423933)
21. miR‑199a decreases Neuritin expression involved in the development of Alzheimer's disease in APP/PS1 mice.
Song D; Li G; Hong Y; Zhang P; Zhu J; Yang L; Huang J
Int J Mol Med; 2020 Jul; 46(1):384-396. PubMed ID: 32626916
[TBL] [Abstract][Full Text] [Related]
22. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
23. Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer's disease.
Wang D; Di X; Fu L; Li Y; Han X; Wu H; Cai L; Meng X; Jiang C; Kong W; Su W
Neuroreport; 2016 Oct; 27(15):1114-9. PubMed ID: 27541273
[TBL] [Abstract][Full Text] [Related]
24. Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.
Wang Y; Zhou Z; Tan H; Zhu S; Wang Y; Sun Y; Li XM; Wang JF
J Alzheimers Dis; 2017; 55(4):1683-1692. PubMed ID: 27911305
[TBL] [Abstract][Full Text] [Related]
25. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I
FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
[TBL] [Abstract][Full Text] [Related]
26. L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.
Zhang Y; Huang LJ; Shi S; Xu SF; Wang XL; Peng Y
CNS Neurosci Ther; 2016 Dec; 22(12):979-987. PubMed ID: 27439966
[TBL] [Abstract][Full Text] [Related]
27. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
[TBL] [Abstract][Full Text] [Related]
28. Muscone Ameliorates Synaptic Dysfunction and Cognitive Deficits in APP/PS1 Mice.
Liu Y; Bian H; Xu S; Shu S; Jia J; Chen J; Cao X; Bao X; Gu Y; Xia S; Yang H; Yu L; Xu Y; Zhu X
J Alzheimers Dis; 2020; 76(2):491-504. PubMed ID: 32538849
[TBL] [Abstract][Full Text] [Related]
29. Traumatic Brain Injury Increases the Expression of Nos1, Aβ Clearance, and Epileptogenesis in APP/PS1 Mouse Model of Alzheimer's Disease.
Miszczuk D; Dębski KJ; Tanila H; Lukasiuk K; Pitkänen A
Mol Neurobiol; 2016 Dec; 53(10):7010-7027. PubMed ID: 26671618
[TBL] [Abstract][Full Text] [Related]
30. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-181a protects against pericyte apoptosis via directly targeting FOXO1: implication for ameliorated cognitive deficits in APP/PS1 mice.
Wu Q; Yuan X; Bai J; Han R; Li Z; Zhang H; Xiu R
Aging (Albany NY); 2019 Aug; 11(16):6120-6133. PubMed ID: 31467256
[TBL] [Abstract][Full Text] [Related]
32. β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy.
Deng M; Huang L; Ning B; Wang N; Zhang Q; Zhu C; Fang Y
Brain Res; 2016 Dec; 1652():188-194. PubMed ID: 27737765
[TBL] [Abstract][Full Text] [Related]
33. Osthole Upregulates BDNF to Enhance Adult Hippocampal Neurogenesis in APP/PS1 Transgenic Mice.
Liu H; Xue X; Shi H; Qi L; Gong D
Biol Pharm Bull; 2015; 38(10):1439-49. PubMed ID: 26424009
[TBL] [Abstract][Full Text] [Related]
34. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of TIPE2, a Negative Regulator of Innate and Adaptive Immunity, Attenuates Cognitive Deficits in APP/PS1 Mice.
Miao Y; Wang N; Shao W; Xu Z; Yang Z; Wang L; Ju C; Zhang R; Zhang F
J Neuroimmune Pharmacol; 2019 Sep; 14(3):519-529. PubMed ID: 31286344
[TBL] [Abstract][Full Text] [Related]
36. miR-124 regulates cerebromicrovascular function in APP/PS1 transgenic mice via C1ql3.
Li AD; Tong L; Xu N; Ye Y; Nie PY; Wang ZY; Ji LL
Brain Res Bull; 2019 Nov; 153():214-222. PubMed ID: 31499089
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
[TBL] [Abstract][Full Text] [Related]
38. Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.
Sadowski M; Pankiewicz J; Scholtzova H; Ji Y; Quartermain D; Jensen CH; Duff K; Nixon RA; Gruen RJ; Wisniewski T
J Neuropathol Exp Neurol; 2004 May; 63(5):418-28. PubMed ID: 15198121
[TBL] [Abstract][Full Text] [Related]
39. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy.
Miettinen R; Riedel A; Kalesnykas G; Kettunen HP; Puoliväli J; Soininen H; Arendt T
J Chem Neuroanat; 2005 Oct; 30(2-3):105-18. PubMed ID: 16081247
[TBL] [Abstract][Full Text] [Related]
40. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
